Cosmos Health targets 2029 revenue USD 200.6 million, net income USD 31 million

• Cosmos Health issued 2029 guidance for revenue of USD 200.6 million, gross profit of USD 71.2 million, adjusted EBITDA of USD 44.2 million.
• Outlook also targets 2029 net income of USD 31.0 million, with CosmoFarm expected to be central to volume growth.
• CosmoFarm posted Q2 2026 revenue above USD 15 million, implying an annualized run-rate above USD 60 million.
• Automation expansion is expected to support more than USD 40 million of additional annual revenue capacity, positioning CosmoFarm above USD 100 million annualized.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609290930ACCESSWRNAPR_____1226797) on September 29, 2026, and is solely responsible for the information contained therein.